Deva Holding AS (IST:DEVA) 3-Year Revenue Growth Rate : 770.90% (As of Dec. 2024)

View and export this data going back to 1986. Start your Free Trial

What is Deva Holding AS 3-Year Revenue Growth Rate?

Deva Holding AS's Revenue per Share for the three months ended in Dec. 2024 was ₺22.45.

During the past 12 months, Deva Holding AS's average Revenue per Share Growth Rate was -5.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 770.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 101.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 33.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Deva Holding AS was 770.90% per year. The lowest was -71.80% per year. And the median was 18.10% per year.

Competitive Comparison of Deva Holding AS's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Deva Holding AS's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Deva Holding AS's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Deva Holding AS's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Deva Holding AS's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Deva Holding AS 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Deva Holding AS (IST:DEVA) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Deva Holding AS 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Deva Holding AS's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Deva Holding AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Deva Holding AS (IST:DEVA) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Halkali Merkez Mahallesi, Basin Ekspres Caddesi No. 1, Kucukcekmece, Istanbul, TUR

Website

http://www.deva.com.tr

Deva Holding AS is a Turkey-based generic medicine manufacturer. It is engaged in manufacturing and marketing of medicinal products for human use and raw materials. The company also carries out the manufacturing of veterinary drugs, eau de cologne, and medical ampoules. It produces medicines for antineoplastic agents, cardiovascular system, dermatological products, nervous system, respiratory system, urogenital system, among others. It exports pharmaceuticals and pharmaceutical raw materials in countries including Switzerland, Germany, the Netherlands, the United Kingdom and others.

Deva Holding AS Headlines

No Headlines